Market leadership Ora is a long-established, full-service ophthalmic drug and device development firm with a global footprint and a track record of delivering 90+ product approvals over 50 years, making it a trusted partner for pharmaceutical and device companies seeking end-to-end development support.

Global capabilities With offices in the United States, United Kingdom, Australia, and Asia, Ora can support multi-region regulatory submissions and clinical programs, offering geographic flexibility for clients pursuing global market access and faster time-to-market.

Comprehensive services Ora’s integrated pre-clinical and clinical models, data solutions, and regulatory strategy capabilities position it to attract clients seeking streamlined, end-to-end ophthalmic product development, potentially expanding into nearby ocular diagnostics and device integration projects.

Industry credibility A strong history of approvals and an experienced team of ophthalmic experts signals high credibility for prospective clients facing complex regulatory and clinical challenges, enabling Ora to capture projects from startups to large pharma and device companies.

Strategic extensions Given the breadth of tech stack and data-centric approach, there are opportunities to upsell digital and data management services, real-world evidence solutions, and global regulatory optimization to existing clients expanding product portfolios or entering new markets.